Scientists launch major study to unravel mysteries of rare immune diseases
NCT ID NCT00001244
First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 12 times
Summary
This study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn errors of immunity. Researchers will observe up to 500 patients over time using blood tests, imaging, and other exams. The goal is to find better ways to diagnose, treat, and prevent complications, but no experimental treatment is given.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better ways to diagnose, treat, and prevent complications of CVID and related immune disorders.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants, and results may take years to translate into new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLAU SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.